%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Louis-Marie Yindom, Maimuna Mendy, Christopher Bodimeade, Caroline Chambion, Peter Aka, Hilton C. Whittle, Sarah L. Rowland-Jones, Robert Walton
KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 14 0 R/Contents 15 0 R/TrimBox[0 0 612 792]>>
endobj
14 0 obj
[16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R]
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref001)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref002)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref003)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref004)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref005)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref006)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref007)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref008)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref004)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref009)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref010)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref006)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref011)>>
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref012)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref013)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref014)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref015)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref016)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref017)>>
endobj
35 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref018)>>
endobj
36 0 obj
<>/Border[0 0 0]/Dest(Rpone.0188307.ref019)>>
endobj
37 0 obj
<>/Border[0 0 0]/A 38 0 R>>
endobj
38 0 obj
<>
endobj
15 0 obj
[39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R]
endobj
39 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 580.6142 m
199.9998 580.6142 l
199.9998 581.1143 l
575.9997 581.1143 l
f*
0.83 0.64 0.02 0 k
416.9764 497.9339 m
421.7386 497.9339 l
h
f*
203.4142 471.9118 m
208.1764 471.9118 l
h
f*
439.0866 471.9118 m
443.8488 471.9118 l
h
f*
545.3858 445.9465 m
550.148 445.9465 l
h
f*
552.4157 445.9465 m
557.178 445.9465 l
h
f*
559.389 445.9465 m
564.1512 445.9465 l
h
f*
442.4315 419.9244 m
447.1937 419.9244 l
h
f*
449.4614 419.9244 m
454.2236 419.9244 l
h
f*
378.5386 393.9024 m
383.3008 393.9024 l
h
f*
385.5118 393.9024 m
390.274 393.9024 l
h
f*
392.5417 393.9024 m
402.0661 393.9024 l
h
f*
230.4567 354.8976 m
235.2189 354.8976 l
h
f*
253.5307 302.9102 m
263.0551 302.9102 l
h
f*
381.6567 250.9228 m
391.1811 250.9228 l
h
f*
227.7354 198.9354 m
237.2031 198.9354 l
h
f*
239.4709 198.9354 m
248.9953 198.9354 l
h
f*
303.5906 146.948 m
313.115 146.948 l
h
f*
473.2157 133.9087 m
482.7402 133.9087 l
h
f*
239.6409 107.9433 m
249.1654 107.9433 l
h
f*
538.1291 107.9433 m
547.6535 107.9433 l
h
f*
291.2882 81.9213 m
300.8126 81.9213 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(\(which)Tj
3.0733 0 Td
(is)Tj
0.9309 0 Td
(rare)Tj
1.9753 0 Td
(in)Tj
0.9847 0 Td
(West)Tj
2.4885 0 Td
(Africa\))Tj
3.0793 0 Td
(was)Tj
1.9813 0 Td
(also)Tj
2.029 0 Td
(linked)Tj
2.7929 0 Td
(to)Tj
1.0443 0 Td
(e)Tj
0.7698 0 Td
(antigenaemia)Tj
6.1467 0 Td
(\(OR)Tj
2.0469 0 Td
(8.8,)Tj
1.8679 0 Td
(95%)Tj
2.2021 0 Td
(CI)Tj
1.2114 0 Td
(1.360.5\).)Tj
-34.6243 -1.474 Td
(There)Tj
2.8047 0 Td
(were)Tj
2.3632 0 Td
(no)Tj
1.3189 0 Td
(associations)Tj
5.6573 0 Td
(with)Tj
1.9753 0 Td
(cirrhosis)Tj
3.8969 0 Td
(or)Tj
1.098 0 Td
(HCC.)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 667.1055 cm
BT
/F3 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusion)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 650.0976 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Certain)Tj
/F6 1 Tf
3.4015 0 Td
(KIR)Tj
/F0 1 Tf
1.8798 0 Td
(profiles)Tj
3.3956 0 Td
(may)Tj
2.0947 0 Td
(promote)Tj
3.8551 0 Td
(clearance)Tj
4.4996 0 Td
(of)Tj
1.0503 0 Td
(hepatitis)Tj
3.8909 0 Td
(B)Tj
0.8832 0 Td
(surface)Tj
3.4672 0 Td
(antigen)Tj
3.4553 0 Td
(whilst)Tj
2.6914 0 Td
(others)Tj
2.9719 0 Td
(pre-)Tj
-37.5365 -1.474 Td
(dispose)Tj
3.6223 0 Td
(to)Tj
1.0444 0 Td
(e)Tj
0.7698 0 Td
(antigen)Tj
3.4553 0 Td
(carriage)Tj
3.7834 0 Td
(and)Tj
1.8679 0 Td
(high)Tj
2.0827 0 Td
(viral)Tj
2.0231 0 Td
(load.)Tj
2.3572 0 Td
(Larger)Tj
3.0793 0 Td
(studies)Tj
3.3479 0 Td
(are)Tj
1.647 0 Td
(necessary)Tj
4.7324 0 Td
(to)Tj
1.0443 0 Td
(quantify)Tj
-34.857 -1.474 Td
(the)Tj
1.5933 0 Td
(effects)Tj
3.145 0 Td
(of)Tj
1.0443 0 Td
(individual)Tj
/F6 1 Tf
4.3206 0 Td
(KIR)Tj
/F0 1 Tf
1.8738 0 Td
(genes,)Tj
3.1927 0 Td
(haplotypes)Tj
4.995 0 Td
(and)Tj
/F6 1 Tf
1.8678 0 Td
(KIR/HLA)Tj
/F0 1 Tf
4.0819 0 Td
(combinations)Tj
6.0452 0 Td
(on)Tj
1.3129 0 Td
(long-term)Tj
-33.4725 -1.474 Td
(viral)Tj
2.023 0 Td
(carriage)Tj
3.7835 0 Td
(and)Tj
1.8679 0 Td
(risk)Tj
1.7604 0 Td
(of)Tj
1.0444 0 Td
(liver)Tj
2.023 0 Td
(cancer.)Tj
/F6 1 Tf
3.4672 0 Td
(KIR)Tj
/F0 1 Tf
1.8798 0 Td
(status)Tj
2.8645 0 Td
(could)Tj
2.578 0 Td
(potentially)Tj
4.6548 0 Td
(inform)Tj
2.9719 0 Td
(antiviral)Tj
3.6164 0 Td
(therapy)Tj
-34.5348 -1.468 Td
(and)Tj
1.8619 0 Td
(identify)Tj
3.3478 0 Td
(those)Tj
2.6437 0 Td
(at)Tj
1.0443 0 Td
(increased)Tj
4.4996 0 Td
(risk)Tj
1.7605 0 Td
(of)Tj
1.0443 0 Td
(complications)Tj
6.2064 0 Td
(for)Tj
1.3785 0 Td
(enhanced)Tj
4.5533 0 Td
(surveillance.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 529.0015 cm
BT
/F3 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 511.9937 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Hepatocellular)Tj
6.0774 0 Td
(carcinoma)Tj
4.4333 0 Td
(\(HCC\))Tj
2.9877 0 Td
(is)Tj
0.8391 0 Td
(the)Tj
1.457 0 Td
(commonest)Tj
4.9209 0 Td
(form)Tj
2.194 0 Td
(of)Tj
1.0035 0 Td
(primary)Tj
3.4469 0 Td
(liver)Tj
1.9729 0 Td
(cancer)Tj
2.8346 0 Td
(and)Tj
1.7178 0 Td
(responsi-)Tj
-33.8851 -1.2982 Td
(ble)Tj
1.3946 0 Td
(for)Tj
1.3833 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0296 0 Td
(800,000)Tj
3.2995 0 Td
(deaths)Tj
2.7893 0 Td
(annually)Tj
3.6623 0 Td
(worldwide)Tj
4.456 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5988 0 Td
(Developing)Tj
4.8132 0 Td
(countries)Tj
3.9458 0 Td
(carry)Tj
2.2733 0 Td
(the)Tj
1.4684 0 Td
(high-)Tj
-35.4555 -1.3039 Td
(est)Tj
1.3039 0 Td
(burden)Tj
3.1237 0 Td
(of)Tj
1.0148 0 Td
(disease)Tj
3.0161 0 Td
(with)Tj
2.0012 0 Td
(7085%)Tj
3.3959 0 Td
(of)Tj
1.0148 0 Td
(affected)Tj
3.3222 0 Td
(people)Tj
2.8573 0 Td
(living)Tj
2.4718 0 Td
(in)Tj
1.0318 0 Td
(Sub-Saharan)Tj
5.3064 0 Td
(Africa)Tj
2.6872 0 Td
(and)Tj
1.7292 0 Td
(Asia)Tj
-34.2763 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
1.5987 0 Td
(In)Tj
1.1112 0 Td
(The)Tj
1.7801 0 Td
(Gambia,)Tj
3.6227 0 Td
(HCC)Tj
2.313 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(commonest)Tj
4.9266 0 Td
(cancer)Tj
2.846 0 Td
(in)Tj
1.0375 0 Td
(men)Tj
2.0125 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
-22.3708 -1.2983 Td
(Hepatitis)Tj
3.8551 0 Td
(B)Tj
0.7993 0 Td
(\(HBV\))Tj
2.9424 0 Td
(and)Tj
1.7348 0 Td
(C)Tj
0.8787 0 Td
(\(HCV\))Tj
3.0274 0 Td
(viruses)Tj
2.9877 0 Td
(are)Tj
1.4456 0 Td
(both)Tj
2.0636 0 Td
(major)Tj
2.6079 0 Td
(risk)Tj
1.7121 0 Td
(factors)Tj
2.9027 0 Td
(for)Tj
1.3889 0 Td
(liver)Tj
1.9843 0 Td
(cirrhosis)Tj
3.6737 0 Td
(and)Tj
-35.2004 -1.2982 Td
(HCC,)Tj
2.5398 0 Td
(together)Tj
3.5319 0 Td
(with)Tj
2.0013 0 Td
(exposure)Tj
3.8154 0 Td
(to)Tj
1.0261 0 Td
(aflatoxin)Tj
3.7077 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(diet)Tj
1.7348 0 Td
(which)Tj
2.6476 0 Td
(is)Tj
0.8503 0 Td
(common)Tj
3.8438 0 Td
(in)Tj
1.0375 0 Td
(West)Tj
2.2677 0 Td
(Africa)Tj
2.6872 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
-34.1969 -1.3039 Td
(Epidemiological)Tj
6.7067 0 Td
(studies)Tj
2.9877 0 Td
(show)Tj
2.296 0 Td
(that)Tj
1.7802 0 Td
(when)Tj
2.4037 0 Td
(chronic)Tj
3.2882 0 Td
(viral)Tj
1.9956 0 Td
(hepatitis)Tj
3.6113 0 Td
(and)Tj
1.7348 0 Td
(dietary)Tj
2.9934 0 Td
(aflatoxin)Tj
3.7077 0 Td
(are)Tj
1.4513 0 Td
(both)Tj
-34.9566 -1.2983 Td
(present,)Tj
3.3902 0 Td
(the)Tj
1.4683 0 Td
(increase)Tj
3.4696 0 Td
(in)Tj
1.0375 0 Td
(risk)Tj
1.7177 0 Td
(of)Tj
1.0148 0 Td
(HCC)Tj
2.3131 0 Td
(is)Tj
0.8447 0 Td
(at)Tj
0.9525 0 Td
(least)Tj
1.9842 0 Td
(multiplicative)Tj
5.7089 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
2.3074 0 Td
(HBV)Tj
2.2621 0 Td
(and)Tj
1.7291 0 Td
(HCV)Tj
2.3414 0 Td
(infections)Tj
-32.5415 -1.2983 Td
(are)Tj
1.4399 0 Td
(endemic)Tj
3.6454 0 Td
(in)Tj
1.0261 0 Td
(The)Tj
1.7688 0 Td
(Gambia,)Tj
3.617 0 Td
(affecting)Tj
3.6453 0 Td
(over)Tj
1.9673 0 Td
(90%)Tj
1.9218 0 Td
(of)Tj
1.0035 0 Td
(the)Tj
1.4627 0 Td
(population,)Tj
4.8018 0 Td
(with)Tj
1.9899 0 Td
(15%)Tj
1.9219 0 Td
(to)Tj
1.0148 0 Td
(20%)Tj
1.9162 0 Td
(chronically)Tj
-33.1424 -1.3039 Td
(infected)Tj
3.4185 0 Td
(with)Tj
1.9956 0 Td
(hepatitis)Tj
3.617 0 Td
(B)Tj
0.7993 0 Td
(and)Tj
1.7292 0 Td
(3%)Tj
1.4513 0 Td
(hepatitis)Tj
3.617 0 Td
(C)Tj
0.8844 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
3.4752 0 Td
(Detectable)Tj
4.4391 0 Td
(HBV)Tj
2.262 0 Td
(viraemia)Tj
3.6907 0 Td
(confers)Tj
3.1407 0 Td
(a)Tj
0.652 0 Td
(six)Tj
-35.172 -1.2983 Td
(fold)Tj
1.7858 0 Td
(increase)Tj
3.4752 0 Td
(in)Tj
1.0318 0 Td
(risk)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(HCC,)Tj
2.5398 0 Td
(and)Tj
1.7292 0 Td
(higher)Tj
2.8062 0 Td
(levels)Tj
2.3755 0 Td
(\(more)Tj
2.6815 0 Td
(than)Tj
2.0239 0 Td
(10,000)Tj
2.8233 0 Td
(viral)Tj
1.9956 0 Td
(copies/mL)Tj
4.405 0 Td
(in)Tj
1.0375 0 Td
(serum\))Tj
-33.4429 -1.2982 Td
(are)Tj
1.4456 0 Td
(strongly)Tj
3.4753 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(both)Tj
2.0579 0 Td
(HCC)Tj
2.3187 0 Td
(and)Tj
1.7291 0 Td
(cirrhosis)Tj
3.6737 0 Td
(\(17-)Tj
1.8652 0 Td
(and)Tj
1.7291 0 Td
(39-fold)Tj
3.0898 0 Td
(increased)Tj
4.0025 0 Td
(risk)Tj
1.7121 0 Td
(respec-)Tj
-33.3522 -1.3039 Td
(tively\))Tj
2.7042 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
-1.508 -1.2983 Td
(NK)Tj
1.6327 0 Td
(cells)Tj
1.9219 0 Td
(play)Tj
1.8708 0 Td
(an)Tj
1.2019 0 Td
(important)Tj
4.2803 0 Td
(role)Tj
1.7688 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(innate)Tj
2.7383 0 Td
(host)Tj
1.9162 0 Td
(defence)Tj
3.2768 0 Td
(against)Tj
3.0274 0 Td
(viral)Tj
1.9956 0 Td
(infection)Tj
3.7927 0 Td
(and)Tj
-33.1254 -1.2983 Td
(tumour)Tj
3.2711 0 Td
(transformation)Tj
6.2759 0 Td
(and)Tj
1.7291 0 Td
(thus)Tj
1.9332 0 Td
(could)Tj
2.4548 0 Td
(be)Tj
1.1452 0 Td
(important)Tj
4.286 0 Td
(in)Tj
1.0318 0 Td
(protecting)Tj
4.3426 0 Td
(against)Tj
3.0274 0 Td
(chronic)Tj
3.2882 0 Td
(hepatitis)Tj
-32.7853 -1.2982 Td
(infection)Tj
3.7927 0 Td
(and)Tj
1.7291 0 Td
(HCC.)Tj
2.5398 0 Td
(The)Tj
1.7802 0 Td
(actions)Tj
3.0614 0 Td
(of)Tj
1.0148 0 Td
(NK)Tj
1.627 0 Td
(cells)Tj
1.9219 0 Td
(are)Tj
1.4514 0 Td
(mediated)Tj
3.9401 0 Td
(by)Tj
1.1792 0 Td
(direct)Tj
2.5342 0 Td
(cytotoxicity)Tj
4.8812 0 Td
(and)Tj
1.7348 0 Td
(secretion)Tj
-33.1878 -1.3039 Td
(of)Tj
1.0147 0 Td
(cytokines)Tj
3.9969 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
2.0806 0 Td
(Cytotoxicity)Tj
5.125 0 Td
(is)Tj
0.8447 0 Td
(controlled)Tj
4.32 0 Td
(by)Tj
1.1849 0 Td
(tightly)Tj
2.7722 0 Td
(balanced)Tj
3.7644 0 Td
(opposing)Tj
3.9118 0 Td
(signals)Tj
2.9027 0 Td
(from)Tj
2.2053 0 Td
(inhibi-)Tj
-34.1232 -1.2983 Td
(tory)Tj
1.8425 0 Td
(and)Tj
1.7234 0 Td
(activatory)Tj
4.1556 0 Td
(killer-cell)Tj
3.9571 0 Td
(immunoglobulin-like)Tj
8.7987 0 Td
(receptors)Tj
3.9118 0 Td
(\(KIR\))Tj
2.5285 0 Td
(present)Tj
3.1578 0 Td
(on)Tj
1.2699 0 Td
(the)Tj
1.4626 0 Td
(NK)Tj
1.6214 0 Td
(cell)Tj
1.5534 0 Td
(sur-)Tj
-35.9827 -1.2983 Td
(face.)Tj
2.0125 0 Td
(Cytokine)Tj
3.8778 0 Td
(secretion)Tj
3.8438 0 Td
(mediates)Tj
3.7757 0 Td
(interaction)Tj
4.6091 0 Td
(between)Tj
3.5263 0 Td
(NK)Tj
1.6327 0 Td
(cells)Tj
1.9162 0 Td
(and)Tj
1.7348 0 Td
(agents)Tj
2.7496 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(adaptive)Tj
-32.1616 -1.3039 Td
(immune)Tj
3.6226 0 Td
(system)Tj
2.9423 0 Td
(such)Tj
2.058 0 Td
(as)Tj
1.0148 0 Td
(dendritic)Tj
3.8778 0 Td
(cells)Tj
1.9162 0 Td
(and)Tj
1.7348 0 Td
(T)Tj
0.8277 0 Td
(lymphocytes)Tj
5.2554 0 Td
(to)Tj
1.0261 0 Td
(modulate)Tj
4.0025 0 Td
(the)Tj
1.4683 0 Td
(host)Tj
1.9162 0 Td
(immune)Tj
-31.6627 -1.2983 Td
(response)Tj
3.7303 0 Td
(to)Tj
1.0262 0 Td
(pathogens)Tj
4.3029 0 Td
(and)Tj
1.7291 0 Td
(to)Tj
1.0262 0 Td
(abnormal)Tj
4.0875 0 Td
(cells)Tj
1.9219 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
-16.6279 -1.2982 Td
(The)Tj
1.7858 0 Td
(key)Tj
1.593 0 Td
(function)Tj
3.6284 0 Td
(of)Tj
1.0148 0 Td
(KIR)Tj
1.8538 0 Td
(receptors)Tj
3.9175 0 Td
(is)Tj
0.8504 0 Td
(to)Tj
1.0261 0 Td
(survey)Tj
2.8119 0 Td
(the)Tj
1.4684 0 Td
(surfaces)Tj
3.4129 0 Td
(of)Tj
1.0148 0 Td
(other)Tj
2.347 0 Td
(\(target\))Tj
3.1918 0 Td
(cells)Tj
1.9162 0 Td
(to)Tj
1.0262 0 Td
(detect)Tj
-34.0552 -1.3039 Td
(the)Tj
1.4683 0 Td
(presence)Tj
3.7133 0 Td
(or)Tj
1.0999 0 Td
(absence)Tj
3.3392 0 Td
(of)Tj
1.0148 0 Td
(their)Tj
2.1089 0 Td
(cognate)Tj
3.3166 0 Td
(ligands)Tj
3.0727 0 Td
(which)Tj
2.6475 0 Td
(are)Tj
1.4514 0 Td
(human)Tj
3.0784 0 Td
(leukocyte)Tj
4.0195 0 Td
(antigen)Tj
3.2031 0 Td
(\(HLA\))Tj
-33.5336 -1.2983 Td
(class)Tj
2.0466 0 Td
(I)Tj
0.5555 0 Td
(molecules.)Tj
4.4277 0 Td
(KIR)Tj
1.8539 0 Td
(and)Tj
1.7291 0 Td
(HLA)Tj
2.211 0 Td
(interact)Tj
3.2825 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.6519 0 Td
(complex)Tj
3.6227 0 Td
(fashion)Tj
3.1521 0 Td
(which)Tj
2.6532 0 Td
(may)Tj
1.9276 0 Td
(result)Tj
2.4491 0 Td
(in)Tj
1.0375 0 Td
(target)Tj
2.5058 0 Td
(cell)Tj
-35.1437 -1.2983 Td
(death)Tj
2.4321 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
3.2484 0 Td
(Both)Tj
2.1374 0 Td
(activating)Tj
4.1102 0 Td
(and)Tj
1.7291 0 Td
(inhibitory)Tj
4.2349 0 Td
(pathways)Tj
3.9345 0 Td
(are)Tj
1.4456 0 Td
(likely)Tj
2.3528 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(governed)Tj
3.9401 0 Td
(by)Tj
1.1849 0 Td
(signals)Tj
-32.927 -1.3039 Td
(transduced)Tj
4.6544 0 Td
(from)Tj
2.1997 0 Td
(interactions)Tj
4.9606 0 Td
(between)Tj
3.5206 0 Td
(specific)Tj
3.1861 0 Td
(KIR)Tj
1.8425 0 Td
(and)Tj
1.7235 0 Td
(HLA)Tj
2.2053 0 Td
(molecules.)Tj
4.4164 0 Td
(The)Tj
1.7744 0 Td
(control)Tj
3.1125 0 Td
(of)Tj
1.0091 0 Td
(the)Tj
1.4627 0 Td
(sys-)Tj
-36.0678 -1.2983 Td
(tem)Tj
1.7574 0 Td
(is)Tj
0.8504 0 Td
(such)Tj
2.0579 0 Td
(that)Tj
1.7802 0 Td
(reduction)Tj
4.1159 0 Td
(in)Tj
1.0374 0 Td
(MHC)Tj
2.5399 0 Td
(expression,)Tj
4.6941 0 Td
(as)Tj
1.0148 0 Td
(is)Tj
0.8447 0 Td
(often)Tj
2.2847 0 Td
(observed)Tj
3.7984 0 Td
(in)Tj
1.0375 0 Td
(tumours)Tj
3.6283 0 Td
(and)Tj
1.7348 0 Td
(virally)Tj
-33.1764 -1.2982 Td
(infected)Tj
3.4185 0 Td
(cells,)Tj
2.1487 0 Td
(increases)Tj
3.8324 0 Td
(the)Tj
1.4683 0 Td
(likelihood)Tj
4.2349 0 Td
(of)Tj
1.0148 0 Td
(killing)Tj
2.7553 0 Td
(by)Tj
1.1849 0 Td
(NK)Tj
1.6271 0 Td
(cells)Tj
1.9218 0 Td
(because)Tj
3.3222 0 Td
(of)Tj
1.0148 0 Td
(lack)Tj
1.8198 0 Td
(of)Tj
/F13 1 Tf
1.0148 0 Td
[()]TJ
/F7 1 Tf
1.7802 0 Td
(inhibition.)Tj
-32.5585 -1.2983 Td
(This)Tj
1.9842 0 Td
(`missing)Tj
3.5376 0 Td
(self')Tj
1.7518 0 Td
(model)Tj
2.7439 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(])Tj
1.8539 0 Td
(proposed)Tj
3.9514 0 Td
(for)Tj
1.3833 0 Td
(NK)Tj
1.6328 0 Td
(cell)Tj
1.559 0 Td
(detection)Tj
3.9345 0 Td
(of)Tj
1.0148 0 Td
(down)Tj
2.4888 0 Td
(regulation)Tj
4.3086 0 Td
(of)Tj
/F13 1 Tf
1.0148 0 Td
[()-13()]TJ
/F7 1 Tf
2.1373 0 Td
(class)Tj
-35.2967 -1.3039 Td
(I)Tj
0.5612 0 Td
(makes)Tj
/F13 1 Tf
2.7496 0 Td
[()]TJ
/F7 1 Tf
1.7858 0 Td
(genotype)Tj
3.8551 0 Td
(important)Tj
4.286 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(wide)Tj
2.1203 0 Td
(range)Tj
2.4605 0 Td
(of)Tj
1.0148 0 Td
(human)Tj
3.0784 0 Td
(diseases)Tj
3.3788 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
/F13 1 Tf
-25.7837 -1.2983 Td
[()-13()]TJ
/F7 1 Tf
2.1373 0 Td
(class)Tj
2.0466 0 Td
(I)Tj
0.5612 0 Td
(down)Tj
2.4888 0 Td
(regulation)Tj
4.3087 0 Td
(by)Tj
1.1792 0 Td
(hepatitis)Tj
3.617 0 Td
(B)Tj
0.7993 0 Td
(virus)Tj
2.1997 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(demonstrated)Tj
5.76 0 Td
(in)Tj
1.0318 0 Td
(hepatoblastoma)Tj
-30.9938 -1.2982 Td
(cell)Tj
1.559 0 Td
(lines)Tj
2.0636 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(])Tj
1.8539 0 Td
(and)Tj
1.7291 0 Td
(decreased)Tj
4.1385 0 Td
(NK)Tj
1.6271 0 Td
(cell)Tj
1.5591 0 Td
(activity)Tj
3.118 0 Td
(is)Tj
0.8504 0 Td
(also)Tj
1.7688 0 Td
(seen)Tj
1.9729 0 Td
(in)Tj
1.0375 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
1.9955 0 Td
(liver)Tj
1.9843 0 Td
(cancer)Tj
2.8459 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
2.075 0 Td
(In)Tj
-35.5462 -1.3039 Td
(addition,)Tj
3.821 0 Td
(the)Tj
1.4684 0 Td
(degree)Tj
2.8573 0 Td
(of)Tj
1.0148 0 Td
(reduction)Tj
4.1158 0 Td
(in)Tj
1.0319 0 Td
(NK)Tj
1.6327 0 Td
(cell)Tj
1.559 0 Td
(function)Tj
3.6284 0 Td
(may)Tj
1.9275 0 Td
(be)Tj
1.1509 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(increased)Tj
4.0025 0 Td
(risk)Tj
1.7121 0 Td
(of)Tj
-36.1755 -1.2983 Td
(more)Tj
2.3414 0 Td
(invasive)Tj
3.4299 0 Td
(disease)Tj
3.016 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
2.0806 0 Td
(Several)Tj
3.0444 0 Td
(studies)Tj
2.9877 0 Td
(have)Tj
2.0579 0 Td
(investigated)Tj
4.989 0 Td
(the)Tj
1.474 0 Td
(role)Tj
1.7688 0 Td
(of)Tj
/F13 1 Tf
1.0148 0 Td
[()]TJ
/F7 1 Tf
1.7801 0 Td
(genes)Tj
2.4435 0 Td
(in)Tj
1.0318 0 Td
(a)Tj
0.6576 0 Td
(range)Tj
2.4605 0 Td
(of)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 457.3984 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(KIR)Tj
1.8708 0 Td
(and)Tj
1.8497 0 Td
(hepatitis)Tj
3.8764 0 Td
(B)Tj
0.8787 0 Td
(in)Tj
0.978 0 Td
(The)Tj
1.9205 0 Td
(Gambia)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01883)Tj
4.089 0 Td
(07)Tj
0 g
2.0906 0 Td
(November)Tj
4.7622 0 Td
(17,)Tj
1.5875 0 Td
(2017)Tj
32.5561 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(14)Tj
/F10 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(manuscript.)Tj
4.6417 0 Td
(ICF)Tj
1.4174 0 Td
(International)Tj
4.8401 0 Td
(is)Tj
0.8363 0 Td
(currently)Tj
3.4937 0 Td
(paying)Tj
2.6717 0 Td
(PA)Tj
-17.9009 -1.3748 Td
(salaries,)Tj
3.2456 0 Td
(but)Tj
1.4245 0 Td
(did)Tj
1.3535 0 Td
(not)Tj
1.4244 0 Td
(have)Tj
1.956 0 Td
(any)Tj
1.5378 0 Td
(role)Tj
1.6157 0 Td
(in)Tj
0.8859 0 Td
(the)Tj
1.3748 0 Td
(study)Tj
-14.8182 -1.3749 Td
(design,)Tj
2.8984 0 Td
(data)Tj
1.7929 0 Td
(collection)Tj
3.7418 0 Td
(and)Tj
1.5874 0 Td
(analysis,)Tj
3.4087 0 Td
(decision)Tj
3.2953 0 Td
(to)Tj
-16.7245 -1.3748 Td
(publish,)Tj
3.1464 0 Td
(or)Tj
0.9993 0 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
1.3677 0 Td
(manuscript.)Tj
/F9 1 Tf
-10.9063 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F10 1 Tf
0.4819 0 Td
(This)Tj
1.7788 0 Td
(recent)Tj
2.5228 0 Td
(commer)Tj
3.1253 0 Td
(cial)Tj
-15.619 -1.3748 Td
(affiliation)Tj
3.5504 0 Td
(does)Tj
2.0055 0 Td
(not)Tj
1.4244 0 Td
(alter)Tj
1.8213 0 Td
(in)Tj
0.8858 0 Td
(any)Tj
1.5307 0 Td
(way)Tj
1.7079 0 Td
(our)Tj
1.4741 0 Td
(adherenc)Tj
3.4087 0 Td
(e)Tj
-17.8088 -1.3748 Td
(to)Tj
0.9496 0 Td
(all)Tj
1.0275 0 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
1.8709 0 Td
(policies)Tj
3.0048 0 Td
(on)Tj
1.1693 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
1.7929 0 Td
(and)Tj
ET
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
endstream
endobj
55 0 obj
<>stream
endstream
endobj
56 0 obj
<>stream
endstream
endobj
57 0 obj
<>stream
endstream
endobj
58 0 obj
<>stream
endstream
endobj
59 0 obj
<>stream
BT
0 73.7155 Td
(materials.)Tj
ET
Q
endstream
endobj
60 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 63 0 R/Contents 64 0 R/TrimBox[0 0 612 792]>>
endobj
62 0 obj
<>stream
x N QYCגo=R
Q*;IED
iB Q
l%ZhѾ4}Gos<3;˝'Ӯ/[uVؗH_~姟~z+{ܹ~۾}%K~~|7Ngw|vaN7lذtm۶Q̾DA ->tfϞ=tc[jʕ+ȡ!-ȡ